PC
TNDM icon

Polar Capital’s Tandem Diabetes Care TNDM Stock Holding History

Polar Capital’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$29M Buy
255,573
+251,140
+5,665% +$26.4M 0.22% 105
2020
Q2 		$439K Hold
4,433
– – ﹤0.01% 257
2020
Q1 		$285K Buy
+4,433
New +$311K ﹤0.01% 282
2019
Q4 		– Sell
-559,605
Closed -$33M – 308
2019
Q3 		$33M Buy
559,605
+247,239
+79% +$15.8M 0.3% 106
2019
Q2 		$20.2M Buy
+312,366
New +$20.2M 0.18% 149

Other funds holding TNDM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Polar Capital's TNDM Position: Q3 2020 in Review

Polar Capital increased its Tandem Diabetes Care (TNDM) stake by 5,665% in Q3 2020, buying an estimated $26.4M and bringing the position to 255,573 shares worth $29M. The position accounts for 0.22% of the portfolio, ranked #105.

Polar Capital first reported a position in TNDM in Q2 2019 and has held it in 5 quarters since. The position peaked at $33M in Q3 2019. 321 funds tracked by Wall St. Rank hold TNDM as of Q3 2020.

  • Polar Capital held 255,573 shares of Tandem Diabetes Care worth $29M as of Q3 2020.
  • Polar Capital bought 251,140 Tandem Diabetes Care shares in Q3 2020, an estimated $26.4M.
  • Tandem Diabetes Care made up 0.22% of Polar Capital's portfolio in Q3 2020, its #105 holding.
  • Polar Capital first reported a position in Tandem Diabetes Care in Q2 2019 and has held it in 5 quarters since.
  • Polar Capital's Tandem Diabetes Care position peaked at $33M in Q3 2019.
  • 321 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2020.

Based on Polar Capital's 13F filing for Q3 2020, filed 16 Nov 2020.